{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T11:47:06Z","timestamp":1781264826505,"version":"3.54.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,5,10]],"date-time":"2016-05-10T00:00:00Z","timestamp":1462838400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,5,10]],"date-time":"2016-05-10T00:00:00Z","timestamp":1462838400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["5 U10 HD021373-31"],"award-info":[{"award-number":["5 U10 HD021373-31"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["5UL1TR000371-08"],"award-info":[{"award-number":["5UL1TR000371-08"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13063-016-1367-4","type":"journal-article","created":{"date-parts":[[2016,5,10]],"date-time":"2016-05-10T02:53:25Z","timestamp":1462848805000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Stopping guidelines for an effectiveness trial: what should the protocol specify?"],"prefix":"10.1186","volume":"17","author":[{"given":"Jon E.","family":"Tyson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Pedroza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"D\u2019Angio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward F.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhik","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,10]]},"reference":[{"key":"1367_CR1","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1136\/bmj.305.6847.235","volume":"305","author":"SJ Pocock","year":"1992","unstructured":"Pocock SJ. When to stop a clinical trial. BMJ. 1992;305:235\u201340.","journal-title":"BMJ."},{"key":"1367_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta9070","volume":"9","author":"AM Grant","year":"2005","unstructured":"Grant AM, Altman DG, Babiker AB, Campbell MK, Clemens FJ, Darbyshire JH, et al. Issues in data monitoring and interim analysis of trials. Health Technol Assess. 2005;9:1\u2013238. iii\u2013iv.","journal-title":"Health Technol Assess"},{"key":"1367_CR3","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jclinepi.2007.07.016","volume":"61","author":"D Bassler","year":"2008","unstructured":"Bassler D, Montori VM, Briel M, Glasziou P, Guyatt G. Early stopping of randomized clinical trials for overt efficacy is problematic. J Clin Epidemiol. 2008;61:241\u20136.","journal-title":"J Clin Epidemiol"},{"key":"1367_CR4","doi-asserted-by":"publisher","first-page":"e3863","DOI":"10.1136\/bmj.e3863","volume":"344","author":"GH Guyatt","year":"2012","unstructured":"Guyatt GH, Briel M, Glasziou P, Bassler D, Montori VM. Problems of stopping trials early. BMJ. 2012;344:e3863.","journal-title":"BMJ"},{"key":"1367_CR5","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1161\/CIRCHEARTFAILURE.111.965707","volume":"5","author":"F Zannad","year":"2012","unstructured":"Zannad F, Gattis Stough W, McMurray JJV, Remme WJ, Pitt B, Borer JS, et al. When to stop a clinical trial early for benefit: lessons learned and future approaches. Circ Heart Fail. 2012;5:294\u2013302.","journal-title":"Circ Heart Fail"},{"key":"1367_CR6","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1177\/1740774506073467","volume":"3","author":"SJ Pocock","year":"2006","unstructured":"Pocock SJ. Current controversies in data monitoring for clinical trials. Clin Trials. 2006;3:513\u201321.","journal-title":"Clin Trials."},{"key":"1367_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2307\/2530298","volume":"38","author":"SJ Pocock","year":"1982","unstructured":"Pocock SJ. Interim analyses for randomized clinical trials: the group sequential approach. Biometrics. 1982;38:153\u201362.","journal-title":"Biometrics"},{"key":"1367_CR8","doi-asserted-by":"publisher","first-page":"549","DOI":"10.2307\/2530245","volume":"35","author":"PC O\u2019Brien","year":"1979","unstructured":"O\u2019Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics. 1979;35:549\u201356.","journal-title":"Biometrics"},{"key":"1367_CR9","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2307\/2531962","volume":"43","author":"NL Geller","year":"1987","unstructured":"Geller NL, Pocock SJ. Interim analyses in randomized clinical trials: ramifications and guidelines for practitioners. Biometrics. 1987;43:213\u201323.","journal-title":"Biometrics"},{"key":"1367_CR10","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1016\/S0140-6736(99)03464-9","volume":"354","author":"DL DeMets","year":"1999","unstructured":"DeMets DL, Pocock SJ, Julian DG. The agonising negative trend in monitoring of clinical trials. Lancet. 1999;354:1983\u20138.","journal-title":"Lancet"},{"key":"1367_CR11","doi-asserted-by":"publisher","first-page":"579","DOI":"10.2307\/2531870","volume":"44","author":"KK Lan","year":"1988","unstructured":"Lan KK, Wittes J. The B-value: a tool for monitoring data. Biometrics. 1988;44:579\u201385.","journal-title":"Biometrics"},{"key":"1367_CR12","volume-title":"Data monitoring committees in clinical trials: a practical perspective","author":"SS Ellenberg","year":"2003","unstructured":"Ellenberg SS, Fleming TR, DeMets DL. Data monitoring committees in clinical trials: a practical perspective. Chichester: Wiley; 2003."},{"key":"1367_CR13","volume-title":"ICH guidance documents","author":"U.S. Food and Drug Administration","year":"2013","unstructured":"U.S. Food and Drug Administration. ICH guidance documents. 2013. \n                    http:\/\/www.fda.gov\/ScienceResearch\/SpecialTopics\/RunningClinicalTrials\/GuidancesInformationSheetsandNotices\/ucm219488.htm\n                    \n                  . Accessed 4 Apr 2016."},{"key":"1367_CR14","volume-title":"Clinical epidemiology: the essentials","author":"RH Fletcher","year":"2005","unstructured":"Fletcher RH, Fletcher SW. Clinical epidemiology: the essentials. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2005.","edition":"4"},{"key":"1367_CR15","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0095-5108(03)00023-X","volume":"30","author":"JC Sinclair","year":"2003","unstructured":"Sinclair JC. Weighing risks and benefits in treating the individual patient. Clin Perinatol. 2003;30:251\u201368.","journal-title":"Clin Perinatol."},{"key":"1367_CR16","doi-asserted-by":"publisher","first-page":"e003143","DOI":"10.1136\/bmjopen-2013-003143","volume":"3","author":"M Marcucci","year":"2013","unstructured":"Marcucci M, Sinclair JC. A generalised model for individualising a treatment recommendation based on group-level evidence from randomised clinical trials. BMJ Open. 2013;3:e003143.","journal-title":"BMJ Open."},{"key":"1367_CR17","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1001\/jama.294.17.2228","volume":"294","author":"SJ Pocock","year":"2005","unstructured":"Pocock SJ. When (not) to stop a clinical trial for benefit. JAMA. 2005;294:2228\u201330.","journal-title":"JAMA."},{"key":"1367_CR18","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1001\/jama.283.21.2829","volume":"283","author":"FA McAlister","year":"2000","unstructured":"McAlister FA, Straus SE, Guyatt GH, Haynes RB. Users\u2019 guides to the medical literature: XX. Integrating research evidence with the care of the individual patient. Evidence-Based Medicine Working Group. JAMA. 2000;283:2829\u201336.","journal-title":"JAMA."},{"key":"1367_CR19","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.jclinepi.2013.02.003","volume":"66","author":"JC Andrews","year":"2013","unstructured":"Andrews JC, Sch\u00fcnemann HJ, Oxman AD, Pottie K, Meerpohl JJ, Coello PA, et al. GRADE guidelines: 15. Going from evidence to recommendation\u2014determinants of a recommendation\u2019s direction and strength. J Clin Epidemiol. 2013;66:726\u201335.","journal-title":"J Clin Epidemiol"},{"key":"1367_CR20","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1378\/chest.13-0746","volume":"144","author":"PO Vandvik","year":"2013","unstructured":"Vandvik PO, Brandt L, Alonso-Coello P, Treweek S, Akl EA, Kristiansen A, et al. Creating clinical practice guidelines we can trust, use, and share: a new era is imminent. Chest. 2013;144:381\u20139.","journal-title":"Chest"},{"key":"1367_CR21","unstructured":"Patient-Centered Outcomes Research Institute. \n                    www.pcori.org\n                    \n                  . Accessed 4 Apr 2016."},{"key":"1367_CR22","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1002\/(SICI)1097-0258(19970630)16:12<1413::AID-SIM578>3.0.CO;2-U","volume":"16","author":"PM Fayers","year":"1997","unstructured":"Fayers PM, Ashby D, Parmar MK. Tutorial in biostatistics: Bayesian data monitoring in clinical trials. Stat Med. 1997;16:1413\u201330.","journal-title":"Stat Med."},{"key":"1367_CR23","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1136\/bmj.319.7208.508","volume":"319","author":"DJ Spiegelhalter","year":"1999","unstructured":"Spiegelhalter DJ, Myles JP, Jones DR, Abrams KR. An introduction to Bayesian methods in health technology assessment. BMJ. 1999;319:508\u201312.","journal-title":"BMJ."},{"key":"1367_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/nrd1927","volume":"5","author":"DA Berry","year":"2006","unstructured":"Berry DA. Bayesian clinical trials. Nat Rev Drug Discov. 2006;5:27\u201336.","journal-title":"Nat Rev Drug Discov."},{"key":"1367_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1017\/S0266462301104034","volume":"17","author":"FE Harrell","year":"2001","unstructured":"Harrell FE, Shih YC. Using full probability models to compute probabilities of actual interest to decision makers. Int J Technol Assess Health Care. 2001;17:17\u201326.","journal-title":"Int J Technol Assess Health Care."},{"key":"1367_CR26","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0140-6736(01)05558-1","volume":"358","author":"MK Parmar","year":"2001","unstructured":"Parmar MK, Griffiths GO, Spiegelhalter DJ, Souhami RL, Altman DG, van der Scheuren E, et al. Monitoring of large randomised clinical trials: a new approach with Bayesian methods. Lancet. 2001;358:375\u201381.","journal-title":"Lancet."},{"key":"1367_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jclinepi.2008.07.006","volume":"62","author":"DN Wijeysundera","year":"2009","unstructured":"Wijeysundera DN, Austin PC, Hux JE, Beattie WS, Laupacis A. Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials. J Clin Epidemiol. 2009;62:13\u201321. e5.","journal-title":"J Clin Epidemiol"},{"key":"1367_CR28","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0378-3782(85)90049-0","volume":"10","author":"I Chalmers","year":"1985","unstructured":"Chalmers I, Sinclair JC. Promoting perinatal health: is it time for a change of emphasis in research? Early Hum Dev. 1985;10:171\u201391.","journal-title":"Early Hum Dev."},{"key":"1367_CR29","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1177\/1740774512454600","volume":"9","author":"J Wittes","year":"2012","unstructured":"Wittes J. Stopping a trial early \u2014 and then what? Clin Trials. 2012;9:714\u201320.","journal-title":"Clin Trials."},{"key":"1367_CR30","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1002\/sim.4780071204","volume":"7","author":"MD Hughes","year":"1988","unstructured":"Hughes MD, Pocock SJ. Stopping rules and estimation problems in clinical trials. Stat Med. 1988;7:1231\u201342.","journal-title":"Stat Med."},{"key":"1367_CR31","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1001\/jama.2010.310","volume":"303","author":"D Bassler","year":"2010","unstructured":"Bassler D, Briel M, Montori VM, et al. Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis. JAMA. 2010;303:1180\u20137.","journal-title":"JAMA."},{"key":"1367_CR32","volume-title":"Grade definitions","author":"U.S. Preventive Services Task Force","year":"2014","unstructured":"U.S. Preventive Services Task Force. Grade definitions. 2014. \n                    http:\/\/www.uspreventiveservicestaskforce.org\/Page\/Name\/grade-definitions\n                    \n                  . Accessed 4 Apr 2016."},{"key":"1367_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/0-387-30107-0","volume-title":"Data Monitoring in clinical trials","author":"DL DeMets","year":"2006","unstructured":"DeMets DL, Friedman LM, Furberg CD. Data Monitoring in clinical trials. New York: Springer; 2006."},{"key":"1367_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/0471740136","volume-title":"Clinical trials: a methodologic perspective","author":"S Piantadosi","year":"2005","unstructured":"Piantadosi S. Clinical trials: a methodologic perspective. 2nd ed. Hoboken: Wiley; 2005.","edition":"2"},{"key":"1367_CR35","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1177\/1740774506073115","volume":"3","author":"DL Demets","year":"2006","unstructured":"Demets DL. Futility approaches to interim monitoring by data monitoring committees. Clin Trials. 2006;3:522\u20139.","journal-title":"Clin Trials."},{"key":"1367_CR36","volume-title":"Bayesian approaches to clinical trials and health care evaluation","author":"DJ Spiegelhalter","year":"2004","unstructured":"Spiegelhalter DJ. Bayesian approaches to clinical trials and health care evaluation. Chichester: Wiley; 2004."},{"key":"1367_CR37","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1371\/journal.pmed.0040026","volume":"4","author":"B Djulbegovic","year":"2007","unstructured":"Djulbegovic B, Hozo I. When should potentially false research findings be considered acceptable? PLoS Med. 2007;4:e26.","journal-title":"PLoS Med."},{"key":"1367_CR38","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1177\/1740774514531352","volume":"11","author":"BR Saville","year":"2014","unstructured":"Saville BR, Connor JT, Ayers GD, Alvarez J. The utility of Bayesian predictive probabilities for interim monitoring of clinical trials. Clin Trials. 2014;11:485\u201393.","journal-title":"Clin Trials."},{"key":"1367_CR39","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1745-6215-8-14","volume":"8","author":"AJ Vickers","year":"2007","unstructured":"Vickers AJ, Kattan MW, Sargent D. Method for evaluating prediction models that apply the results of randomized trials to individual patients. Trials. 2007;8:14.","journal-title":"Trials."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-016-1367-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-016-1367-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-016-1367-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-016-1367-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T10:58:44Z","timestamp":1589540324000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-016-1367-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,10]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1367"],"URL":"https:\/\/doi.org\/10.1186\/s13063-016-1367-4","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,10]]},"assertion":[{"value":"15 October 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"240"}}